Global Aneurysm Market, By Type (Ruptured Aneurysm, Leaking Aneurysm, Unruptured Aneurysm, Others), Treatment (Surgery, Medication, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Aneurysm Market Analysis and Size
The global aneurysm market is expected to witness significant growth during the forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market. Rising prevalence of neurological disorders worldwide and emerging markets are the factors responsible for the growth of this market. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global aneurysm market in the forecast period 2022-2029. The expected CAGR of global aneurysm market is tend to be around 9% in the mentioned forecast period. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Aneurysm is the condition of weakening of artery wall that creates a bulge, distention of the artery. Most of the aneurysm cannot show any symptoms and not dangerous but, in severe cases they can rupture and causes serious life threating condition. According to centers for disease control and lack of prevention in aortic aneurysms contribute to over 25,000 deaths and around 30,000 deaths due to brain aneurysms rupture in the United States (U.S.) each year. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period
Aneurysm Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Ruptured Aneurysm, Leaking Aneurysm, Unruptured Aneurysm, Others), Treatment (Surgery, Medication, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Pfizer Inc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Mylan N.V. (U.S.), Fresenius Kabi AG (Germany), Hikma Pharmaceuticals PLC (Japan), Novartis AG (U.S), Teva Pharmaceutical Industries Ltd. (Israel), HEYER Medical AG (Germany), Smiths Medical, Inc (U.S.), Johnson & Johnson Services, Inc. (U.S.), Arbor Pharmaceuticals (Ireland)
|
|
Market Opportunities
|
|
Global Aneurysm Market Dynamics
Drivers
- Increase in Geriatric Population
The geriatric population is expected to increase the patient population globally, which boots the global brain aneurysm market in the forecast period. According to the WHO, the global elderly population is expected to reach around 2 billion by 2050 from 617 million in 2015. This boost the market growth.
- Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
Opportunities
- Increased Incidence of Hypertension
The cases of hypertension is rising due to several reasons like the sudden increase in the blood pressure which eventually affects other diseases like the heart, brain, and kidney. The population with the age group 35 to 60 years is more prone to this diseased condition. Its incidence is increasing and its treatment is of great importance to the healthcare sector.
Restraints/Challenges
- Lack of Skilled Professionals
Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global aneurysm market over a forecast period.
- High Cost
The huge expenditure of the treatment methods surely hamper the market growth.
This global brain aneurysm market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global brain aneurysm market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Aneurysm Market Scope
The global aneurysm market is segmented on the basis of type, treatment type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Ruptured Aneurysm
- Leaking Aneurysm
- Unruptured Aneurysm
- Others
Treatment
- Surgery
- Medication
- Others
Route of Administration
- Oral
- Parenteral
- Others
End-Users
- Hospitals
- Homecare
- Speciality Centres
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Aneurysm Market Regional Analysis/Insights
The global aneurysm market is analysed and market size insights and trends are provided by type, treatment type, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global aneurysm market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific is expected to have the highest market growth due to rising incidence of cardiovascular disorders.
North America dominates the market due to high prevalence of brain injuries & increased alcohol consumption and rapidly improving health care infrastructure in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Aneurysm Market Share Analysis
The global aneurysm market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global aneurysm market.
Key players operating in the global aneurysm market include:
- Pfizer Inc (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Mylan N.V. (U.S.)
- Fresenius Kabi AG (Germany)
- Hikma Pharmaceuticals PLC (Japan)
- Novartis AG (U.S)
- Teva Pharmaceutical Industries Ltd. (Israel)
- HEYER Medical AG (Germany)
- Smiths Medical, Inc (U.S.)
- Johnson & Johnson Services, Inc. (U.S.)
- Arbor Pharmaceuticals (Ireland)
SKU-